Previous Article | Next Article 
Molecular and Cellular Biology, May 2002, p. 2906-2917, Vol. 22, No. 9
0270-7306/02/$04.00+0 DOI: 10.1128/MCB.22.9.2906-2917.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
DNA Methyltransferase Deficiency Modifies Cancer Susceptibility in Mice Lacking DNA Mismatch Repair
Binh N. Trinh,1 Tiffany I. Long,1 Andrea E. Nickel,1 Darryl Shibata,1,2 and Peter W. Laird1,3*
Department of Biochemistry and Molecular Biology,1
Department of Pathology,2
Department of Surgery, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California 90089-91763
Received 30 October 2001/
Returned for modification 14 January 2002/
Accepted 29 January 2002
We have introduced DNA methyltransferase 1 (Dnmt1) mutations into a mouse strain deficient for the Mlh1 protein to study the interaction between DNA mismatch repair deficiency and DNA methylation. Mice harboring hypomorphic Dnmt1 mutations showed diminished RNA expression and DNA hypomethylation but developed normally and were tumor free. When crossed to Mlh1-/- homozygosity, they were less likely to develop the intestinal cancers that normally arise in this tumor-predisposed, mismatch repair-deficient background. However, these same mice developed invasive T- and B-cell lymphomas earlier and at a much higher frequency than their Dnmt1 wild-type littermates. Thus, the reduction of Dnmt1 activity has significant but opposing outcomes in the development of two different tumor types. DNA hypomethylation and mismatch repair deficiency interact to exacerbate lymphomagenesis, while hypomethylation protects against intestinal tumors. The increased lymphomagenesis in Dnmt1 hypomorphic, Mlh1-/- mice may be due to a combination of several mechanisms, including elevated mutation rates, increased expression of proviral sequences or proto-oncogenes, and/or enhanced genomic instability. We show that CpG island hypermethylation occurs in the normal intestinal mucosa, is increased in intestinal tumors in Mlh1-/- mice, and is reduced in the normal mucosa and tumors of Dnmt1 mutant mice, consistent with a role for Dnmt1-mediated CpG island hypermethylation in intestinal tumorigenesis.
* Corresponding author. Mailing address: Norris Comprehensive Cancer Center, 1441 Eastlake Ave., Los Angeles, CA 90089-9176. Phone: (323) 865-0650. Fax: (323) 865-0158. E-mail:
plaird{at}hsc.usc.edu.
Molecular and Cellular Biology, May 2002, p. 2906-2917, Vol. 22, No. 9
0022-538X/02/$04.00+0 DOI: 10.1128/MCB.22.9.2906-2917.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Josefowicz, S. Z., Wilson, C. B., Rudensky, A. Y.
(2009). Cutting Edge: TCR Stimulation Is Sufficient for Induction of Foxp3 Expression in the Absence of DNA Methyltransferase 1. J. Immunol.
182: 6648-6652
[Abstract]
[Full Text]
-
Ecke, I., Petry, F., Rosenberger, A., Tauber, S., Monkemeyer, S., Hess, I., Dullin, C., Kimmina, S., Pirngruber, J., Johnsen, S. A., Uhmann, A., Nitzki, F., Wojnowski, L., Schulz-Schaeffer, W., Witt, O., Hahn, H.
(2009). Antitumor Effects of a Combined 5-Aza-2'Deoxycytidine and Valproic Acid Treatment on Rhabdomyosarcoma and Medulloblastoma in Ptch Mutant Mice. Cancer Res.
69: 887-895
[Abstract]
[Full Text]
-
Suijkerbuijk, K. P. M., Fackler, M. J., Sukumar, S., van Gils, C. H., van Laar, T., van der Wall, E., Vooijs, M., van Diest, P. J.
(2008). Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer. Ann Oncol
19: 1870-1874
[Abstract]
[Full Text]
-
Lopes, E. C., Valls, E., Figueroa, M. E., Mazur, A., Meng, F.-G., Chiosis, G., Laird, P. W., Schreiber-Agus, N., Greally, J. M., Prokhortchouk, E., Melnick, A.
(2008). Kaiso Contributes to DNA Methylation-Dependent Silencing of Tumor Suppressor Genes in Colon Cancer Cell Lines. Cancer Res.
68: 7258-7263
[Abstract]
[Full Text]
-
Dion, V., Lin, Y., Hubert, L. Jr., Waterland, R. A., Wilson, J. H.
(2008). Dnmt1 deficiency promotes CAG repeat expansion in the mouse germline. Hum Mol Genet
17: 1306-1317
[Abstract]
[Full Text]
-
Brena, R. M., Costello, J. F.
(2007). Genome-epigenome interactions in cancer. Hum Mol Genet
16: R96-R105
[Abstract]
[Full Text]
-
Wojdacz, T. K., Dobrovic, A.
(2007). Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation. Nucleic Acids Res
35: e41-e41
[Abstract]
[Full Text]
-
McCabe, M. T., Low, J. A., Daignault, S., Imperiale, M. J., Wojno, K. J., Day, M. L.
(2006). Inhibition of DNA Methyltransferase Activity Prevents Tumorigenesis in a Mouse Model of Prostate Cancer. Cancer Res.
66: 385-392
[Abstract]
[Full Text]
-
Kaneda, A., Feinberg, A. P.
(2005). Loss of Imprinting of IGF2: A Common Epigenetic Modifier of Intestinal Tumor Risk. Cancer Res.
65: 11236-11240
[Abstract]
[Full Text]
-
Kim, Y.-I.
(2005). Nutritional Epigenetics: Impact of Folate Deficiency on DNA Methylation and Colon Cancer Susceptibility. J. Nutr.
135: 2703-2709
[Abstract]
[Full Text]
-
Lyko, F., Brown, R.
(2005). DNA Methyltransferase Inhibitors and the Development of Epigenetic Cancer Therapies. JNCI J Natl Cancer Inst
97: 1498-1506
[Abstract]
[Full Text]
-
Melnick, A. M., Adelson, K., Licht, J. D.
(2005). The Theoretical Basis of Transcriptional Therapy of Cancer: Can It Be Put Into Practice?. JCO
23: 3957-3970
[Abstract]
[Full Text]
-
McCabe, M. T., Davis, J. N., Day, M. L.
(2005). Regulation of DNA Methyltransferase 1 by the pRb/E2F1 Pathway. Cancer Res.
65: 3624-3632
[Abstract]
[Full Text]
-
Laird, P. W.
(2005). Cancer epigenetics. Hum Mol Genet
14: R65-R76
[Abstract]
[Full Text]
-
Das, P. M., Singal, R.
(2004). DNA Methylation and Cancer. JCO
22: 4632-4642
[Abstract]
[Full Text]
-
Kim, M., Trinh, B. N., Long, T. I., Oghamian, S., Laird, P. W.
(2004). Dnmt1 deficiency leads to enhanced microsatellite instability in mouse embryonic stem cells. Nucleic Acids Res
32: 5742-5749
[Abstract]
[Full Text]
-
Karpf, A. R., Lasek, A. W., Ririe, T. O., Hanks, A. N., Grossman, D., Jones, D. A.
(2004). Limited Gene Activation in Tumor and Normal Epithelial Cells Treated with the DNA Methyltransferase Inhibitor 5-Aza-2'-deoxycytidine. Mol. Pharmacol.
65: 18-27
[Abstract]
[Full Text]
-
Kopelovich, L., Crowell, J. A., Fay, J. R.
(2003). The Epigenome as a Target for Cancer Chemoprevention. JNCI J Natl Cancer Inst
95: 1747-1757
[Abstract]
[Full Text]
-
Carnell, A. N., Goodman, J. I.
(2003). The Long (LINEs) and the Short (SINEs) of It: Altered Methylation as a Precursor to Toxicity. Toxicol Sci
75: 229-235
[Abstract]
[Full Text]
-
Fan, T., Yan, Q., Huang, J., Austin, S., Cho, E., Ferris, D., Muegge, K.
(2003). Lsh-deficient Murine Embryonal Fibroblasts Show Reduced Proliferation with Signs of Abnormal Mitosis. Cancer Res.
63: 4677-4683
[Abstract]
[Full Text]
-
Klatt, P., Serrano, M.
(2003). Engineering cancer resistance in mice. Carcinogenesis
24: 817-826
[Abstract]
[Full Text]
-
Gaudet, F., Hodgson, J. G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J. W., Leonhardt, H., Jaenisch, R.
(2003). Induction of Tumors in Mice by Genomic Hypomethylation. Science
300: 489-492
[Abstract]
[Full Text]
-
Bariol, C., Suter, C., Cheong, K., Ku, S.-L., Meagher, A., Hawkins, N., Ward, R.
(2003). The Relationship between Hypomethylation and CpG Island Methylation in Colorectal Neoplasia. Am. J. Pathol.
162: 1361-1371
[Abstract]
[Full Text]